← Back to Search

Behavioral Intervention

Stress Management Program for Von Hippel-Lindau Syndrome

N/A

Waitlist Available

Led By Giselle Perez, PhD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Confirmed diagnosis of VHL

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-treatment completion (treatment is approximately 2 months)

Awards & highlights

Study Summary

This trial will study how an adapted stress management program can help people with a chronic illness better cope with their condition. #chronicillness #stressmanagement

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of Von Hippel-Lindau (VHL) disease, which is a genetic disorder. Participants must be able to engage in videoconferencing sessions and not have any medical or psychiatric conditions that would prevent full participation as assessed by a physician.Check my eligibility

What is being tested?

The study tests an adapted Relaxation Response Resiliency Program (3RP-VHL), designed to help VHL patients cope better with their condition. It's about learning stress management techniques specifically tailored for those living with this chronic illness.See study design

What are the potential side effects?

Since the intervention involves stress management and resilience training, there are no direct physical side effects like you'd expect from medication. However, participants may experience emotional discomfort when discussing personal challenges related to VHL.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with Von Hippel-Lindau disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-treatment completion (treatment is approximately 2 months)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-treatment completion (treatment is approximately 2 months)

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-treatment completion (treatment is approximately 2 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

3RP-VHL Acceptability: Five Questions

3RP-VHL Feasibility: Percent of Identified Eligibles Who Enroll

3RP-VHL Feasibility: Proportion of Participants Completing the 3RP-VHL Program

Trial Design

1Treatment groups

Experimental Treatment

Group I: 3RP-VHLExperimental Treatment1 Intervention

An adapted version of the 3RP (3RP-VHL) for individuals with VHL. The adapted program incorporates the three prongs of the 3RP: RR elicitation, stress awareness, and adaptive strategies. It will be delivered in weekly sessions over the course of approximately 8 weeks. Complete pre- and post-intervention surveys.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

The Rappaport FoundationUNKNOWN

The Claflin Distinguished Scholar AwardsUNKNOWN

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,315 Total Patients Enrolled

Media Library

3RP-VHL (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05737602 — N/A

Von Hippel-Lindau Syndrome Research Study Groups: 3RP-VHL

Von Hippel-Lindau Syndrome Clinical Trial 2023: 3RP-VHL Highlights & Side Effects. Trial Name: NCT05737602 — N/A

3RP-VHL (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05737602 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor have open enrollment at the moment?

"Per the clinicaltrials.gov listing, this investigation is no longer looking for participants and has not been updated since February 10th 2023. Nonetheless, there are currently 49 active trials with open recruitment opportunities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

Giselle K. Perez Lougee 2023. "Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05737602.